MSD | pharmaphorum

Friday 27 February 2026

MSD

News

MSD headquarters

MSD splits pharma business, hiving off oncology

MSD is separating its cancer and non-cancer pharma operations as it prepares for the looming loss of patent protection for $31bn blockbuster Keytruda.

News

MSD and Mayo Clinic at screen

MSD and Mayo Clinic team up on AI drug discovery

MSD has signed an industry-first deal with the Mayo Clinic that will allow it to use the health system's genomic and clinical data for drug discovery.

News

CMS's Medicare price negotiations start round three

The US federal government has named the next 15 big-selling medicines that will be subject to Medicare pricing negotiations.

News

Pedestrian crossing green and red lights

MSD said to have pulled back from Revolution Meds deal

Negotiations between MSD and Revolution Medicines over a possible $30bn takeover of Revolution Medicines have reportedly collapsed.

News

Data builds behind Moderna's skin cancer vaccine

Data builds behind Moderna's skin cancer vaccine

Five-year results with Moderna/MSD's melanoma jab show a 49% reduction in disease progression or death, boding well for phase 3 data later this year.

News

Illumina hq

JPM: Illumina launches 'unprecedented' disease biology atlas

Illumina says its new Billion Cell Atlas can be used to identify and validate drug targets and train AI models used in drug discovery.